Literature DB >> 12547359

Bone mineral density correlates with fracture load in experimental side impacts of the pelvis.

David P Beason1, Greg J Dakin, Robert R Lopez, Jorge E Alonso, Faris A Bandak, Alan W Eberhardt.   

Abstract

Pelvic fractures resulting from automotive side impacts are associated with high mortality and morbidity, as well as substantial economic costs. Previous experimental studies have produced varying results regarding the tolerance of the pelvis to lateral force and compression. While bone mineral density (BMD) has been shown to correlate with fracture loads in the proximal femur, no such correlation has been established for the pelvis. Presently, we studied the relationships between total hip BMD and impact response parameters in lateral impacts of twelve isolated human pelves. The results indicated that total hip BMD significantly correlated with fracture force, Fmax, and maximum ring compression, Cmax, of the fractured pelves. These findings are evidence that BMD may be useful in assessing the risk of pelvic fracture in automotive side impacts. Poor correlation was observed between total hip BMD and maximum viscous response, (VC)max, energy at fracture, Epeak, and time to fracture, tpeak. Mean Fmax and calculated tolerances for Cmax and (VC)max were lower than those established in previous studies using full cadavers, likely a result of our removal of soft tissues from the pelves prior to impact.

Entities:  

Mesh:

Year:  2003        PMID: 12547359     DOI: 10.1016/s0021-9290(02)00330-5

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  9 in total

Review 1.  Biomechanics of side impact: injury criteria, aging occupants, and airbag technology.

Authors:  Narayan Yoganandan; Frank A Pintar; Brian D Stemper; Thomas A Gennarelli; John A Weigelt
Journal:  J Biomech       Date:  2006-03-09       Impact factor: 2.712

2.  True compression of pelvic fractures under lateral impact.

Authors:  Zhijian Ma; Zizheng Wu; Liping Bai; Chun Bi; Xiangsen Zeng; Aili Qu; Qiugen Wang
Journal:  Int Orthop       Date:  2018-07-18       Impact factor: 3.075

3.  Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.

Authors:  Kyeong-Ok Choi; Inae Lee; Sae-Yeol-Rim Paik; Dong Eun Kim; Jung Dae Lim; Wie-Soo Kang; Sanghoon Ko
Journal:  J Med Food       Date:  2012-10       Impact factor: 2.786

4.  Comminuted olecranon fracture fixation with pre-contoured plate: Comparison of composite and cadaver bones.

Authors:  David A Hamilton; Danielle Reilly; Felix Wipf; Srinath Kamineni
Journal:  World J Orthop       Date:  2015-10-18

5.  Bone density and cortical thickness in normal, osteopenic, and osteoporotic sacra.

Authors:  Andrew M Richards; Nathan W Coleman; Trevor A Knight; Stephen M Belkoff; Simon C Mears
Journal:  J Osteoporos       Date:  2010-06-09

6.  Dynamic Simulation of Biomechanical Behaviour of the Pelvis in the Lateral Impact Loads.

Authors:  Mohsen Hatami; Dongmei Wang; Aili Qu; Zeng Xiangsen; Qiugen Wang; Behzad Baradaran Kazemian
Journal:  J Healthc Eng       Date:  2018-09-18       Impact factor: 2.682

7.  On the internal reaction forces, energy absorption, and fracture in the hip during simulated sideways fall impact.

Authors:  Ingmar Fleps; William S Enns-Bray; Pierre Guy; Stephen J Ferguson; Peter A Cripton; Benedikt Helgason
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

8.  Survivorship and severe complications are worse for octogenarians and elderly patients with pelvis fractures as compared to adults: data from the national trauma data bank.

Authors:  Amir Matityahu; Joshua Elson; Saam Morshed; Meir Marmor
Journal:  J Osteoporos       Date:  2012-11-07

9.  A novel sideways fall simulator to study hip fractures ex vivo.

Authors:  Ingmar Fleps; Muriel Vuille; Angela Melnyk; Stephen J Ferguson; Pierre Guy; Benedikt Helgason; Peter A Cripton
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.